Drug Type AAV based gene therapy |
Synonyms Adeno-associated virus 9 methylmalonyl Co-A mutase (NHGRI/NIH) |
Target |
Action modulators |
Mechanism MUT modulators(Methylmalonyl-CoA Mutase modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Methylmalonic Acidemia | Preclinical | United States | 25 Oct 2024 |





